Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06677086 · ClinicalTrials.gov registry record · NA
HIFEM for Musculoskeletal System Improvement
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT06677086 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 36 participants.
The verdict
NCT06677086, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to investigate the effect of the BTL-899 device on improving the Musculoskeletal System in healthy adult volunteers. The main question it aims to answer is: Whether the BTL-899 device is able to change musculoskeletal system perception before and after treatment, based on the Subject Satisfaction questionnaire. Participants will complete four treatments, and two follow-up visits.
Interventions
- DEVICE Treatment with BTL-899
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2025-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06677086
The ClinicalTrials.gov registry entry for NCT06677086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with BTL-899 is the first listed.
NCT06677086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06677086 about?
NCT06677086 is a clinical study titled "HIFEM for Musculoskeletal System Improvement". The goal of this clinical trial is to investigate the effect of the BTL-899 device on improving the Musculoskeletal System in healthy adult volunteers. The main question it aims to answer is: Whether the BTL-899 device is able to change musculoskeletal system perception before and after treatment, ...
What is the current status of trial NCT06677086?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2024-05-08. Estimated completion is 2025-01-22.
What interventions are being tested in trial NCT06677086?
The interventions under investigation include: Treatment with BTL-899 (DEVICE).
Who is sponsoring clinical trial NCT06677086?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.